Trials / Completed
CompletedNCT01576861
Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
After the encouraging results of 6 months of Growth Hormone Replacement Therapy in Patients With Chronic Heart Failure and Coexisting Growth Hormone Deficiency (NCT00591760) the investigators wanted to collect data about the long-term efficacy and safety of this kind of therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatotropin | Subcutaneous Somatotropin (recombinant Human Growth Hormone) 0,012 mg/kg every second day |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2011-03-01
- Completion
- 2011-12-01
- First posted
- 2012-04-13
- Last updated
- 2012-10-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01576861. Inclusion in this directory is not an endorsement.